Loading company
Generate Biomedicines, Inc.
GENB · Nasdaq · ·
Next earnings: November 5, 2026
$15.42+3.5%Sep 29 close
- 1M
- +0.6%
- 6M
- +34.0%
GENB · Nasdaq · ·
Next earnings: November 5, 2026
$15.42+3.5%Sep 29 close
Generate Biomedicines, Inc. is scheduled to report next on November 5, 2026. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.
From the company’s own 8-K filing.
“Our team’s focus on execution for our clinical programs and translating our generative biology platform into the next generation of differentiated medicines drove strong progress in the second quarter,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
Releases land after the close or before the open, so the move is the session that follows.
The quote and the company description come from Generate Biomedicines, Inc.’s Item 2.02 8-K filed August 6, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Generate Biomedicines, Inc. has no earnings call transcript available.